Hacker, Miriam
Firk, Christine
Konrad, Kerstin
Paschke, Kerstin
Neulen, Joseph
Herpertz-Dahlmann, Beate
Dahmen, Brigitte
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KR1207B, 01KR1803A)
RWTH Aachen University
Article History
Received: 5 February 2021
Accepted: 17 June 2021
First Online: 29 July 2021
Ethics approval and consent to participate
: The study was approved by the local ethics committee of the medical faculty of the University hospital RWTH Aachen, Germany, and undertaken according to the Declaration of Helsinki and Good Clinical Practice (GCP) regulations. All participants, legal guardians, and parents gave written informed consent before enrolment in the study.
: Not applicable.
: BHD has received a speaking stipend from Ferring. JN has received speaking fees from Bayer, Ferring, Jenapharm, Kade-Bessins, MSD, Mylan, and Gedeon Richter. He works on the advisory boards of Gedeon Richter, Kade-Bessins, and Shionogi and fulfilled an advisory role for Mylan and TEVA. All other authors declare that they have no conflicts of interest or competing interests.